Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Passive Leg Raise: An Indispensable Maneuver in the Study of Heart Failure with Preserved Ejection Fraction

Heart failure (HF) with preserved ejection fraction (HFpEF) accounts for at least 50% of the HF population, with an increasing prevalence. Its diagnosis is based on the presence of typical symptoms and increased filling pressures, with an ejection fraction greater than 50%.

SOLACI

In some cases—especially in the earlier stages of the disease—, laboratory and echocardiographic markers may be suboptimal to diagnose HFeEF, because filling pressures only increase in the presence of physiological stress (occult-HFpEF). Therefore, invasive tests such as pulmonary artery catheterization (PAC) with exercise should be considered an excellent option in these scenarios.

The possibility of performing exercise during PAC presents technical difficulties, so maneuvers that rapidly increase venous return, including passive leg raise (PLR), have been proposed as an alternative.

The aim of this study was to determine whether the PLR maneuver during PAC can be used to increase the diagnostic yield or rule out the diagnosis of occult-HFpEF.

The study included 109 patients from a tertiary pulmonary hypertension and HFpEF center, mainly women, with a mean age of 64 years, diagnosed with HFpEF using the H2FPEF score. These patients underwent CAP with pulmonary capillary wedge pressure (PCWP) measurement. They were categorized into three groups: Manifest-HFpEF (PCWPREST ≥15 mm Hg and PCWPEXERCISE ≥25 mm Hg), occult-HFpEF (PCWPREST <15 mm Hg and PCWPEXERCISE ≥25 mm Hg), or non-HFpEF (PCWPREST <15 mm Hg and PCWPEXERCISE <25 mm Hg). The PLR maneuver consisted in the raising of a leg at 50° by an assistant for 3 minutes.

Read also: Should Aspirin Be the Standard of Secondary Prevention of MACE?

PCWPPLR had a significantly higher predictive value for the diagnosis of occult-HFpEF, compared with PCWPREST (AUC = 0.82 vs. 0.69, p = 0.03). 

PCWPPLR ≥19 can be used as an unequivocal cut-off point, with a specificity and positive predictive value of 100%, while a cut-off point of PCWPPLR <11 can be used to rule out occult-HFpEF (>11 has a 100% sensitivity). These cut-off points were subsequently confirmed in an external validation cohort.

Conclusions

In this study, incorporating the PLR maneuver during PAC significantly increased the diagnostic yield compared with resting measurements. This test is risk-free and less time consuming (when compared with a water overload challenge). Therefore, it should be considered an invaluable tool in the hemodynamic study of patients with suspected HFpEF.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board, SOLACI.org .

Original Title: The Value of Passive Leg Raise During Right Heart Catheterization in Diagnosing Heart Failure With Preserved Ejection Fraction.

Source: van de Bovenkamp AA, et al. Circ Heart Fail [Internet]. 2022; CIRCHEARTFAILURE121008935.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...